Skip to main content

Table 1 Clinical and biochemical characteristic of PCOS patients (n = 217) and normal controls (n = 144)

From: The promoter -1031(T/C) polymorphism in tumor necrosis factor-alpha associated with polycystic ovary syndrome

Characteristics

PCOS patients (n = 217)

Controls (n = 144)

Age (y)

32.47 ± 3.04 (29-35)

33.09 ± 3.36 (29-36)

BMI (kg/m2)

34.99 ± 5.84 (24.38-56.23)

18.77 ± 2.13 (15.04-25.08)

Waist/hip ratio (WHR)

1.23 ± 0.09 (1.00-2.24)

0.72 ± 0.06 (0.63-0.82)

FSH (mIU/ml)

8.75 ± 2.75 (1.50-29.98)

5.93 ± 1.64 (2.71-12.22)

LH (mIU/ml)

12.61 ± 9.87 (1.50-37.67)

2.93 ± 1.34 (1.01-6.43)

E2 (pg/ml)

64.69 ± 52.11 (7.53-133.36)

29.4 ± 13.7 (3.84-58.05)

Prolactin (ng/ml)

20.22 ± 14.52 (3.46-108.80)

11.08 ± 5.86 (3.71-42.02)

TSH (μIU/ml)

3.39 ± 2.15 (0.69-15.74)

1.7 ± 0.85 (0.02-3.67)

DHEA-S (μg/dl)

298.48 ± 115.34

(68.26-568.41)

142.96 ± 50.22

(60.86-233.11)

Testosterone (ng/ml)

0.87 ± 0.31 (0.09-1.29)

0.22 ± 0.13 (0.01-0.48)

  1. Numerical data were presented as means ± standard deviation (SD). Abbreviations: BMI, Body mass index: WHR, Waist-hip ratio: FSH, Follicle-stimulating hormone: LH, Luteinizing hormone: E2, Estradiol: TSH, Thyroid-stimulating hormone; DHEA-S, Dehydroepiandrosterone-sulfate